Search - Prime Therapeutics
366 Results for GLP-1 Pipeline Update
-
publications FDA Decisions Expected Drug pipeline for November 2024 October 14, 2024 Your monthly synopsis of new drugs expected to hit the market At Prime Therapeutics (Prime), we have...
-
publications High Cost Therapy Profile: November 2024 Zenocutuzumab Intravenous (IV) November 20, 2024 Oncology Proposed indications Pancreatic ductal adenocarcinoma (PDAC) and non–small...
-
Jessica Johnson, clinical consultant at Prime Therapeutics, shares how the Special Investigations Unit (SIU) helps prevent fraud, waste and abuse (FWA) in health care
Prime Article: Perspectives -
Managed Healthcare Executive
PA Sub-Categories: GLP-1 Prime Article: In the News
Compliance / Legal
Careers
© 2025 Prime Therapeutics LLC